期刊文献+

骨髓增生异常综合征诊断分型的研究进展 被引量:4

原文传递
导出
摘要 骨髓增生异常综合征(MDS)是一组造血干细胞克隆性疾病,其诊断分型一直在不断的探讨中。垄断几乎20年的FAB分型存在的一系列问题促使WHO分型的出台,国际预后评分系统(IPSS)在MDS的诊断分型中具有不可替代的作用,但仍需不断改进,检测WT1的水平有望成为MDS危险度评估的一种手段,正确评估端粒的动态变化可能为MDS的预后提供另一种手段。
出处 《白血病.淋巴瘤》 CAS 2005年第3期183-186,共4页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献31

  • 1Bennett J, Catovasky D, Daniel M, et al. Proposals for the classification of the myelodysplastic syndromes[J]. Br J Haemotal, 1982,51(2):189-199.
  • 2Nosslinger T, Reisner R, Koller E, et al.Myelodysplastic syndromes from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution[J]. Blood, 2001, 98(10): 2935-2941.
  • 3肖志坚,郝玉书.骨髓增生异常综合征的诊断分型与预后判断及疗效标准[J].中华内科杂志,2002,41(12):846-848. 被引量:49
  • 4Harris N, Jaffe E, Diebold J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997[J]. Hematol, 2000, 1(1):53-66.
  • 5Germing U, Gattermann N, Strupp C, et al.Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients[J]. Leuk Res, 2000, 24(12):983-992.
  • 6Lee J, Lee J, Shin Y, et al. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodyaplaafic syndrome[J]. Leukemia, 2003, 17(2):305-313.
  • 7朱平,冯茹,曹香红,董玉君,岑溪南.骨髓增生异常综合征世界卫生组织新分型的临床评价[J].中华血液学杂志,2004,25(6):362-364. 被引量:10
  • 8Howe R B, Porwit- MacDonald A, Wanat R,et al. The WHO classification of MDS does make a difference[J]. Blood, 2004, 103(9):3265-3270.
  • 9Bain B. The WHO classification of the myelodysplastics[J]. Exp Oncol, 2004, 26(3):166-169.
  • 10林凤茹,郭晓楠,陈建彬.世界卫生组织关于骨髓增生异常综合征和骨髓增生异常或骨髓增殖性疾病的分类和诊断标准[J].临床荟萃,2004,19(12):719-720. 被引量:4

二级参考文献23

  • 1Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House Virginia,November 1997. Mod Pathol, 2000,13 : 193-207.
  • 2Naeim F, ed. Pathology of bone marrow. Baltimore: Williams & Wilkins, 1997. 140-160.
  • 3Heaney ML, Golde DW. Myelodysplasia. N Engl J Meal,1999,340:1649-1660.
  • 4Naeim F. Atlas of bone marrow and blood pathology. Saunders:Wiliams & Wilkins, 2001.31-45.
  • 5陈书长,白血病,1995年,4期,121页
  • 6姚尔固,新编白血病化疗学,1999年,188页
  • 7Young N S,Blood,1992年,79卷,1385页
  • 8Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol, 1982, 51: 189-199.
  • 9Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997. J Clin Oncol, 1999,
  • 10Germing U, Gattermann N, Minning H, et al. Problems in the classification of CMML dysplastic versus proliferative type. Leuk Res, 1998, 22: 871-878.

共引文献118

同被引文献28

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部